CHINA PHARMA HOLDINGS, INC. Long-term Debt, Weighted Average Interest Rate, at Point in Time
CHINA PHARMA HOLDINGS, INC. (CPHI) had Long-term Debt, Weighted Average Interest Rate, at Point in Time of 85.00% as of 2022-08-03, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:LongtermDebtWeightedAverageInterestRate · last filed 2022-11-14
- 2022-08-03: Long-term Debt, Weighted Average Interest Rate, at Point in Time 85.00%.
- 2022-06-09: Long-term Debt, Weighted Average Interest Rate, at Point in Time 85.00%.
- 2022-03-30: Long-term Debt, Weighted Average Interest Rate, at Point in Time 85.00%.
- 2022-03-21: Long-term Debt, Weighted Average Interest Rate, at Point in Time 85.00%.
| Period end | Long-term Debt, Weighted Average Interest Rate, at Point in Time |
|---|---|
| 2022-08-03 | 85.00% 10-Q · filed 2022-11-14 |
| 2022-06-09 | 85.00% 10-Q · filed 2022-11-14 |
| 2022-03-30 | 85.00% 10-Q · filed 2022-11-14 |
| 2022-03-21 | 85.00% 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |